Galliprant® (grapiprant tablets)
Help your patients enjoy the everyday moments that matter. Prescribe Galliprant to deliver targeted and effective pain relief from osteoarthritis pain and inflammation in dogs.
Why Choose Galliprant?
First-in-class non-COX inhibiting NSAID
Targeted Mode of Action
Use for All Stages of OA*
Safe to Use Daily
Galliprant Product Information
An NSAID that controls pain and inflammation associated with osteoarthritis in dogs.
Chewable tablet
Grapiprant
Galliprant Dosing and Administration
| Weight (lbs) - 8-15 |
| Weight (kg) - 3.6-6.8 |
| 20mg Tablet - 0.5 tablet |
| 60mg Tablet - - |
| 100mg Tablet - - |
| Weight (lbs) - 15.1-30 |
| Weight (kg) - 6.8-13.6 |
| 20mg Tablet - 1 tablet |
| 60mg Tablet - - |
| 100mg Tablet - - |
| Weight (lbs) - 30.1-45 |
| Weight (kg) - 13.7-20.4 |
| 20mg Tablet - - |
| 60mg Tablet - 0.5 tablet |
| 100mg Tablet - - |
| Weight (lbs) - 45.1-75 |
| Weight (kg) - 20.5-34 |
| 20mg Tablet - - |
| 60mg Tablet - 1 tablet |
| 100mg Tablet - - |
| Weight (lbs) - 75.1-150 |
| Weight (kg) - 34.1-68 |
| 20mg Tablet - - |
| 60mg Tablet - - |
| 100mg Tablet - 1 tablet |
| Weight (lbs) | Weight (kg) | 20mg Tablet | 60mg Tablet | 100mg Tablet |
|---|---|---|---|---|
| 8-15 | 3.6-6.8 | 0.5 tablet | - | - |
| 15.1-30 | 6.8-13.6 | 1 tablet | - | - |
| 30.1-45 | 13.7-20.4 | - | 0.5 tablet | - |
| 45.1-75 | 20.5-34 | - | 1 tablet | - |
| 75.1-150 | 34.1-68 | - | - | 1 tablet |
Mechanism of Action
First-in-class prostaglandin receptor antagonist (PRA); a non-COX inhibiting NSAID that specifically targets the EP4 receptor1
Mode of action targets canine OA pain and inflammation while reducing the impact on GI, kidney and liver homeostasis1,2†
Galliprant® (grapiprant tablets) Resources
2024 Galliprant Master Detailer
Integrate Galliprant into an expert-recommended, staged approach to treatment.
Galliprant First Line Choice Technical Bulletin
Discover why experts recommend daily NSAID therapy as the cornerstone of OA treatment.
How to Get Galliprant
Incorporate Galliprant into your canine OA protocol today.
Indication
Galliprant controls pain and inflammation associated with osteoarthritis in dogs.
Important Safety Information
For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and decreases in serum albumin and total protein. Click here for full prescribing information.
